Dec 10, 2014 ... And since trastuzumab, and not chemotherapy alone, is the standard of care for the HER2-positive sub-class of breast cancer, there is no need to ...
Jun 3, 2018 ... "This results in many women being overtreated, because endocrine therapy would be adequate," he explained. Oncotype DX is a commercially ...
Jul 29, 2019 ... The other authors have disclosed no relevant financial relationships. Ann Surg Oncol. Published online July 22, 2019. Abstract. For more from ...
Oct 20, 2018 ... ... does not require the use of steroids, whereas as paclitaxel does require some use of steroids, at least initially." Schmid said that, as ...
Jul 12, 2022 ... Cancer cells do not handle stress well, so they may be more vulnerable to concomitant chemotherapy and calorie restriction.” Low-protein diet ...
Sep 30, 2021 ... ... no response to the COVID-19 vaccine. ... To get the clearest answer possible, they focused on patients with solid tumors, such as breast or ...
Sep 29, 2019 ... Schmid told the press conference it is not surprising that chemotherapy and immunotherapy should work together to improve response rates in TNBC ...
Mar 12, 2021 ... They also converted most patients with estrogen receptor–positive breast cancers, who would usually receive traditional intravenous chemotherapy ...
Apr 2, 2021 ... ... chemo- and radiotherapy in TNBC patients. TNBC is an aggressive type of breast cancer with worse survival rates than other forms of the disease.
Jun 3, 2018 ... The first study, described as the largest breast cancer treatment trial to date, found that the majority of women with a common form of breast ...
Sussman had inflammatory, stage IV breast cancer, which had metastasized to her hip. She has now had six months of chemotherapy to shrink the tumors, has ...
Mar 19, 2022 ... No differences in overall and progression-free survival were observed at the GOG-0252 trial update among patients with ovarian cancer who ...
Jun 12, 2022 ... [Still], it's not the sum of our ambitions. The sum of our ambitions should be greater than [synchronizing] chemotherapy and immunotherapy. We ...
Sep 18, 2021 ... Patients with cervical cancer receiving pembrolizumab plus chemotherapy with or without bevacizumab in the frontline setting had improvement ...
Dec 23, 2019 ... Doctors have been advising patients for a number of years not to take antioxidants during chemotherapy, Ambrosone said. "But there was no strong ...